236 related articles for article (PubMed ID: 28718774)
1. Effects of microchannel confinement on acoustic vaporisation of ultrasound phase change contrast agents.
Lin S; Zhang G; Leow CH; Tang MX
Phys Med Biol; 2017 Aug; 62(17):6884-6898. PubMed ID: 28718774
[TBL] [Abstract][Full Text] [Related]
2. Imaging of vaporised sub-micron phase change contrast agents with high frame rate ultrasound and optics.
Lin S; Zhang G; Jamburidze A; Chee M; Leow CH; Garbin V; Tang MX
Phys Med Biol; 2018 Mar; 63(6):065002. PubMed ID: 29384498
[TBL] [Abstract][Full Text] [Related]
3. Decafluorobutane as a phase-change contrast agent for low-energy extravascular ultrasonic imaging.
Sheeran PS; Wong VP; Luois S; McFarland RJ; Ross WD; Feingold S; Matsunaga TO; Dayton PA
Ultrasound Med Biol; 2011 Sep; 37(9):1518-30. PubMed ID: 21775049
[TBL] [Abstract][Full Text] [Related]
4. Pulse sequences for uniform perfluorocarbon droplet vaporization and ultrasound imaging.
Puett C; Sheeran PS; Rojas JD; Dayton PA
Ultrasonics; 2014 Sep; 54(7):2024-33. PubMed ID: 24965563
[TBL] [Abstract][Full Text] [Related]
5. Thermal and Acoustic Stabilization Of Volatile Phase-Change Contrast Agents Via Layer-By-Layer Assembly.
Alcaraz PE; Davidson SJ; Shreeve E; Meuschke R; Romanowski M; Witte RS; Porter TR; Matsunaga TO
Ultrasound Med Biol; 2023 May; 49(5):1058-1069. PubMed ID: 36797095
[TBL] [Abstract][Full Text] [Related]
6. Phase-change contrast agents for imaging and therapy.
Sheeran PS; Dayton PA
Curr Pharm Des; 2012; 18(15):2152-65. PubMed ID: 22352770
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced ultrasound imaging and in vivo circulatory kinetics with low-boiling-point nanoscale phase-change perfluorocarbon agents.
Sheeran PS; Rojas JD; Puett C; Hjelmquist J; Arena CB; Dayton PA
Ultrasound Med Biol; 2015 Mar; 41(3):814-31. PubMed ID: 25619781
[TBL] [Abstract][Full Text] [Related]
8. Vaporization dynamics of volatile perfluorocarbon droplets: a theoretical model and in vitro validation.
Doinikov AA; Sheeran PS; Bouakaz A; Dayton PA
Med Phys; 2014 Oct; 41(10):102901. PubMed ID: 25281982
[TBL] [Abstract][Full Text] [Related]
9. Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells.
Hadinger KP; Marshalek JP; Sheeran PS; Dayton PA; Matsunaga TO
Ultrasound Med Biol; 2018 Dec; 44(12):2728-2738. PubMed ID: 30228045
[TBL] [Abstract][Full Text] [Related]
10. On the acoustic properties of vaporized submicron perfluorocarbon droplets.
Reznik N; Lajoinie G; Shpak O; Gelderblom EC; Williams R; de Jong N; Versluis M; Burns PN
Ultrasound Med Biol; 2014 Jun; 40(6):1379-84. PubMed ID: 24462162
[TBL] [Abstract][Full Text] [Related]
11. Vaporization Detection Imaging: A Technique for Imaging Low-Boiling-Point Phase-Change Contrast Agents with a High Depth of Penetration and Contrast-to-Tissue Ratio.
Rojas JD; Dayton PA
Ultrasound Med Biol; 2019 Jan; 45(1):192-207. PubMed ID: 30482709
[TBL] [Abstract][Full Text] [Related]
12. Optimizing Acoustic Activation of Phase Change Contrast Agents With the Activation Pressure Matching Method: A Review.
Rojas JD; Dayton PA
IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):264-272. PubMed ID: 27740481
[TBL] [Abstract][Full Text] [Related]
13. Phase change events of volatile liquid perfluorocarbon contrast agents produce unique acoustic signatures.
Sheeran PS; Matsunaga TO; Dayton PA
Phys Med Biol; 2014 Jan; 59(2):379-401. PubMed ID: 24351961
[TBL] [Abstract][Full Text] [Related]
14. Characterising the chemical and physical properties of phase-change nanodroplets.
Zhang W; Metzger H; Vlatakis S; Claxton A; Carbajal MA; Fung LF; Mason J; Chan KLA; Pouliopoulos AN; Fleck RA; Prentice P; Thanou M
Ultrason Sonochem; 2023 Jul; 97():106445. PubMed ID: 37257208
[TBL] [Abstract][Full Text] [Related]
15. Slow-Flow Ultrasound Localization Microscopy Using Recondensation of Perfluoropentane Nanodroplets.
Burgess MT; Aliabouzar M; Aguilar C; Fabiilli ML; Ketterling JA
Ultrasound Med Biol; 2022 May; 48(5):743-759. PubMed ID: 35125244
[TBL] [Abstract][Full Text] [Related]
16. Fluorous-phase iron oxide nanoparticles as enhancers of acoustic droplet vaporization of perfluorocarbons with supra-physiologic boiling point.
Vezeridis AM; de Gracia Lux C; Barnhill SA; Kim S; Wu Z; Jin S; Lux J; Gianneschi NC; Mattrey RF
J Control Release; 2019 May; 302():54-62. PubMed ID: 30928487
[TBL] [Abstract][Full Text] [Related]
17. Bubble Inflation Using Phase-Change Perfluorocarbon Nanodroplets as a Strategy for Enhanced Ultrasound Imaging and Therapy.
Brambila CJ; Lux J; Mattrey RF; Boyd D; Borden MA; de Gracia Lux C
Langmuir; 2020 Mar; 36(11):2954-2965. PubMed ID: 32090572
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Vaporised Targeted Nanodroplets Using High-Frame-Rate Ultrasound and Optics.
Zhang G; Lin S; Leow CH; Pang KT; Hernández-Gil J; Long NJ; Eckersley R; Matsunaga T; Tang MX
Ultrasound Med Biol; 2019 May; 45(5):1131-1142. PubMed ID: 30827708
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Assessment of the Potential for Renal Bio-Effects from the Vaporization of Perfluorocarbon Phase-Change Contrast Agents.
Nyankima AG; Rojas JD; Cianciolo R; Johnson KA; Dayton PA
Ultrasound Med Biol; 2018 Feb; 44(2):368-376. PubMed ID: 29254872
[TBL] [Abstract][Full Text] [Related]
20. The efficiency and stability of bubble formation by acoustic vaporization of submicron perfluorocarbon droplets.
Reznik N; Shpak O; Gelderblom EC; Williams R; de Jong N; Versluis M; Burns PN
Ultrasonics; 2013 Sep; 53(7):1368-76. PubMed ID: 23652262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
